ClinicalTrials.gg
CompletedNCT05225441EnCLASS-FSEFUpdated Jul 26, 2022

National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF

An observational study in Psychiatric Disorder, Somatic Symptom and Traumatic Injury, sponsored by Fondation Santé des Étudiants de France. Completed at 1 site in France. Open to participants aged 11 Years to 20 Years. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by Fondation Santé des Étudiants de France · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
598
Ages
11 Years to 20 Years
Sex
All
01

Study summary

For the clinical component:

Describe the young people hospitalised in residential care at the FSEF, in particular through vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, substance use (cannabis, alcohol, tobacco), social relationships, family relationships, well-being, level of health literacy, learning disorders)) and to compare them with young people from the general school population.

For the epidemiological aspect:

To study the construct validity of the EnCLASS questions aiming to characterize handicap situations in the general school population in both a population in situation of psychic handicap and of somatic handicap.

Read the detailed description

Residential care in psychiatry in France, although recommended by the HAS and widely implemented, have been little evaluated In France, the residential care of the FSEF called "soins-études" have long been recognized as contributors to psychosocial rehabilitation. They hospitalize young people with mental and physical disabilities. They allow the continuation of hospital care associated with the resumption of schooling and the implementation of a training project integrated into the individualized care plan. Each year, around 1 500 young people are admitted to full-time hospitalization for "soins-études" in psychiatry or medicine (follow-up care and rehabilitation) within the FSEF. They benefit from comprehensive care, adapted to their needs, including care, maintenance or resumption of schooling and social reintegration in a peer group. A recent review of the literature showed that the provision of "soins-études" in psychiatry allows clinical improvement in nearly two-thirds of between more than 5 years after admissionit, and the resumption of schooling and a training project. The young people admitted at the FSEF generally have been receiving care for more than 3 years for chronic psychiatric disorders. Despite frequent school delays or periods of dropping out of school, a large majority of them had a school activity during the care.

However, it appears from this review that the characteristics of the young people received have never been compared with those of students in a traditional education course. Characterizing this population meets a need, as well as a strong institutional demand (FSEF, funders and national education).

The EnCLASS-FSEF survey will be rolled out with the national EnCLASS methodology in all the annexes of the National Education schools integrated into the 13 FSEF care-study clinics (therefore on the total population in care-studies of the FSEF educated in secondary school) - making it possible to describe and compare the patients treated in care studies with the general school population.

02

Conditions studied

  • Psychiatric Disorder
  • Somatic Symptom
  • Traumatic Injury

Keywords

  • clinical epidemiology
  • Substance use and abuse
  • Psychiatric symptoms
  • Social disabilities
  • Health literacy
03

In context

Mental Disorders

1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.

This study's enrollment of 598 is above the median of 220 across 389 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Fondation Santé des Étudiants de France is the lead sponsor of 9 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All young people hospitalized in care-study in the 13 clinics in the FSEF (i.e. around 1,500) over the period from March to June 2022.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Student cared for in college and high school studies in the 13 clinics of the FSEF,
  • From 11 years old,
  • Non-opposition of the student to his participation in the study and to the use of his data (and of their parents for minor students).

Exclusion criteria

Exclusion Criteria:

  • Student opposition to participating in the study (or their parents for underage students).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
598 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. description of the study population

    Describe the young people taken into "soins étude" at the FSEF for a psychiatric pathology or for a somatic pathology, in particular through characteristic vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, consumption of toxicants (cannabis, alcohol, tobacco), ease of having friends, quality of family relationships, well-being, level of health literacy, "dys" disorders)) and comparison with young people from the general school population. This description and comparison will be carried out thanks to the answers of the young people to the questionnaire of the national survey (identical questionnaire for the population of the FSEF and the national population).

    Time frame: inclusion

Secondary outcomes

  1. comparison

    Compare the levels of psychological symtoms the FSEF population to the general population (response of young people to specific questions on the subject in the national survey questionnaire).

    Time frame: inclusion

  2. frequency

    Frequency of various psychiatric disorders within the FSEF population and description of psychotropic treatments received. Data will be collected both through young people's responses to specific questions aimed at the FSEF population and both from the participants' medical records.

    Time frame: inclusion

07

Study locations

1 site
  • Godart Nathalie
    Paris, 75014, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05225441
Lead sponsor
Fondation Santé des Étudiants de France
Responsible party
Sponsor
First posted
Feb 4, 2022
Start date
Mar 1, 2022
Primary completion
Jun 24, 2022
Completion
Jun 24, 2022
Last update
Jul 26, 2022

Study contacts

Nathalie Godart
study director · Fondation Santé des Etudiants de France

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion